Frequency of antiphospholipid syndrome in women with pregnancy loss in multicenter study in Poland;Częstość występowania zespołu antyfosfolipidowego u kobiet z utratą ciąż w wieloośrodkowych badaniach w Polsce

Ginekologia Polska

Volumn 82, Issue 10, 2011, Pages 749-754

  Jana, Skrzypczak ^a   Marcin, Rajewski ^a   Przemysław, Wirstlein ^a   Tomasz, Goździewicz ^a   Mariusz, Zimmer ^b   Sławomir, Wołczyński ^c   Bozena, Leszczyńska Gorzelak ^d   Grzegorz, Breborowicz ^e   Grzegorz, Ludwikowski ^f  

^a Katedry Ginekologii   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Uniwersytetu Medycznego w Bia ymstoku   (Poland)

^d Uniwersytetu Medycznego w Lublinie   (Poland)

^e Katedra i Klinika Perinatologii   (Poland)

^f NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Anti 2glicoprotein I antibodies; Late pregnancy loss; Lupus anticoagulant; Placental insufficiency; Preeclampsia; Premature deliveries; Recurrent early pregnancy loss

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD; COMPARATIVE STUDY; EMBRYO DEATH; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; POLAND; PREGNANCY; PREGNANCY COMPLICATION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; EMBRYO LOSS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; POLAND; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 80855140035     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Tincani A, Bazzani Ch, Zingarelli S, Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis and treatment. Semin Thromb Hemost. 2008, 34, 267-273.
2. Za{ogonek}bek I, Luft S, Wojciechowska B, [i wsp.]. Badania nad krzyżowa{ogonek} reaktywnościa{ogonek} przeciwciał antyfosfolipidowych w układowych chorobach tkanki ła{ogonek}cznej. Reumatol. 1995, 33, 111-120.
3. Miyakis S, Lockshin M, Atsumi T, [et al.]. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006, 4, 295-306.
4. Zimmermann-Górska I. Kryteria klasyfikacyjne dla zespołu antyfosfolipidowego. Pol Arch Med Wewn. 2006, 115, 396-400.
5. Stephenson M. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996, 66, 24-29.
6. Oshiro B, Silver R, Scott J, [et al.]. Antiphospholipid antibodies and fetal death. Obstet Gynecol. 1996, 87, 489-493.
7. Lima F, Khamashta M, Buchanan N, [et al.]. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheum. 1996, 14, 131-136.
8. Long A, Ginsberg J, Brill-Edwards P, [et al.]. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Hemost. 1991, 66, 520-524.
9. Rajewski M, Skrzypczak J. Cze{ogonek}stość wyste{ogonek}powania przeciwciał antyfosfolipidowych i zespołu antyfosfolipidowego u kobiet z poronieniami nawracaja{ogonek}cymi. Ginekol Pol. 2011, 82, 32-38.
10. Blank M, Krause I, Fridkin M, [et al.]. Bacterial induction of autoantibodies to beta2- glycoprotein-I accounts for the infections etiology of antiphospholipid syndrome. J Clin Invest. 2002, 109, 797-804.
11. Goel N, Ortel T, Bali D, [et al.]. Familial antiphospholipid antibody syndrome: criteria for disease and evidence for autosomal dominant inheritance. Arthritis Rheum. 1999, 42, 318-327.
12. Savi M, Ferraccioli G, Neri T, [et al.]. HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. Arthritis Rheum. 1988, 31, 1568-1570.
13. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome in native mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci USA. 1991, 88, 3069-3073.
14. Meroni P, Riboldi P. Pathogenic mechanism mediating antiphospholipid syndrome. Curr Opin Rheumatol. 2001, 13, 377-382.
15. Di Simone N, Raschi E, Testoni C, [et al.]. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterization of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glucoprotein I antibodies in vitro. Ann Rheum Dis. 2005, 64, 462-467.
16. Girardi G, Berman J, Redecha P, [et al.]. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest. 2003, 112, 211-220.
17. Petri M, Golbus M, Anderson R, [et al.]. Antinuclear antibody, lupus, anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled prospective study of forty-four women. Arthritis Rheum. 1987, 30, 601-606.
18. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. RCOG. 2011, Green-top Guideline no 17.
19. Robertson L, Wu O, Langhorne P, [et al.]. Thrombophilia in pregnancy: a systematic review. Brit. J Haematol. 2005, 132, 171-196.
20. Branch D, Silver R, Pierangeli S, [et al.]. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls and antiphospholipid syndrome. Obstet Gynecol. 1997, 89, 549-555.
21. Stephenson M. Management of recurrent pregnancy loss. J Reprod Med. 2006, 51, 303-310.
22. Simpson J. Genetics of spontaneous abortions. In: Recurrent pregnancy loss. Causes, controversies and treatment. Ed. Carp H. London: Informa Healthcare. 2007, 23-34.
23. Stankiewicz P, Lupski J. Structural variation in the human genome and its role in disease. Ann Rev Med. 2010, 61, 437-455.
24. Chauleur C, Galanaud J, Alonso A, [et al.]. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies. J Thromb Haemost. 2010, 8, 699-706.
25. McIntyre J. Antiphospholipid antibodies in implantation failures. Am J Reprod Immunol. 2003, 49, 221-229.
26. McCarthy G. Seronegative APS (SNAPS) in 53 patients: seroconversion rate at 3,5 years (abstract). J Autoimmun. 2000, 15OC35.
27. Opatrny L, David M, Kahn S, [et al.]. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol. 2006, 33, 2214-2221.
28. Mezzesimi A, Florio P, Reis F, [et al.]. The detection of anti β2-glyceprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in first trimester. Eur J Obstet Gynecol Reprod Biol. 2007, 133, 164-168.
29. Sailer T, Zoghlami C, Kurz C, [et al.]. Anti-beta2glicoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant. Thromb Haemost. 2006, 95, 796-801.
30. Ruffatti A, Tonello M, Del Ross T, [et al.]. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost. 2006, 96, 239-389.
31. Nielsen H, Christiansen O. Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant. Hum Reprod. 2005, 20, 1720-1728.
32. Gris J. Trombophilia and pregnancy loss: cause or association. Thromb Res. 2009, 123, Supp, 105-110.
33. Middeldorp S. Thrombophilia and pregnancy complications: cause or association? J Thromb Haemost. 2007, 5, 276-282.
34. Cervera R, Khamashta MA, Shoenfeld Y, [et al.]. Morbidity and mortality In the antiphospholipid syndrome during a 5-years period: a multicenter prospective study of 1000 patients. Ann Rheum Dis. 2009, 68, 1428-1432.
35. Skrzypczak J, Rajewski M, Wirstlein P, Goździewicz T. Czy mie{ogonek}dzy trombofilia{ogonek} a utrata{ogonek} cia{ogonek}ż istnieje zwia{ogonek}zek przyczynowy? Perinat Neonatol Gin. 2011 - w druku.